ArticleJournal of managed care & specialty pharmacy2022

Budget impact analysis of trilaciclib for decreasing the incidence of chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer in the United States.

Ivo Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.